Tevogen Bio (TVGNW) to Release Quarterly Earnings on Wednesday

Tevogen Bio (NASDAQ:TVGNW) is projected to announce its results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of ($0.03) per share for the quarter.

Tevogen Bio Stock Up 6.3%

NASDAQ TVGNW traded up $0.00 on Friday, reaching $0.05. The stock had a trading volume of 229,167 shares, compared to its average volume of 159,202. The stock has a fifty day moving average price of $0.04 and a two-hundred day moving average price of $0.05. Tevogen Bio has a 12-month low of $0.03 and a 12-month high of $0.09.

Tevogen Bio Company Profile

Tevogen Bio is a clinical-stage biotechnology company focused on developing allogeneic T cell receptor (TCR)-based immunotherapies for the treatment of cancer and infectious diseases. Leveraging a proprietary platform of engineered T cells, the company aims to deliver off-the-shelf cellular products that can recognize and eliminate disease-specific antigens without the need for patient-matched cell manufacturing.

The company’s pipeline encompasses programs targeting chronic viral infections, including hepatitis B virus and SARS-CoV-2, as well as cytomegalovirus, alongside oncology indications such as solid and hematological tumors.